Galapagos “win” highlights crowded idiopathic pulmonary fibrosis pipeline

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 4, 2020 at 10:52 AM.

  1. #1 cafead, Dec 4, 2020 at 10:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Galapagos's decision this week to push on with GLPG1205 in idiopathic pulmonary fibrosis puts another novel mechanism into later-stage trials for the fatal lung condition. New data on the project were not all positive, however, and the jury will remain out on its prospects for now.

    article source
     
    Quote

Reply to Thread